Peter Kubuš
Charles University in Prague
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Peter Kubuš.
Circulation-arrhythmia and Electrophysiology | 2015
Thomas M. Roston; Jeffrey M. Vinocur; Kathleen R. Maginot; Saira Mohammed; Jack C. Salerno; Susan P. Etheridge; Mitchell B. Cohen; Robert M. Hamilton; Andreas Pflaumer; Ronald J. Kanter; James E. Potts; Martin J. LaPage; Kathryn K. Collins; Roman Gebauer; Joel Temple; Anjan S. Batra; Christopher C. Erickson; Maria Miszczak-Knecht; Peter Kubuš; Yaniv Bar-Cohen; Michal J. Kantoch; Vincent C. Thomas; Gabriele Hessling; Chris Anderson; Ming-Lon Young; Michel Cabrera Ortega; Yung R. Lau; Christopher L. Johnsrude; Anne Fournier; Prince J. Kannankeril
Background—Catecholaminergic polymorphic ventricular tachycardia is an uncommon, potentially lethal, ion channelopathy. Standard therapies have high failure rates and little is known about treatment in children. Newer options such as flecainide and left cardiac sympathetic denervation are not well validated. We sought to define treatment outcomes in children with catecholaminergic polymorphic ventricular tachycardia. Methods and Results—This is a Pediatric and Congenital Electrophysiology Society multicenter, retrospective cohort study of catecholaminergic polymorphic ventricular tachycardia patients diagnosed before 19 years of age. The cohort included 226 patients, including 170 probands and 56 relatives. Symptomatic presentation was reported in 176 (78%). Symptom onset occurred at 10.8 (interquartile range, 6.8–13.2) years with a delay to diagnosis of 0.5 (0–2.6) years. Syncope (P<0.001), cardiac arrest (P<0.001), and treatment failure (P=0.008) occurred more often in probands. &bgr;-Blockers were prescribed in 205 of 211 patients (97%) on medication, and 25% experienced at least 1 treatment failure event. Implantable cardioverter defibrillators were placed in 121 (54%) and was associated with electrical storm in 22 (18%). Flecainide was used in 24% and left cardiac sympathetic denervation in 8%. Six deaths (3%) occurred during a cumulative follow-up of 788 patient-years. Conclusions—This study demonstrates a malignant phenotype and lengthy delay to diagnosis in catecholaminergic polymorphic ventricular tachycardia. Probands were typically severely affected. &bgr;-Blockers were almost universally initiated; however, treatment failure, noncompliance and subtherapeutic dosing were often reported. Implantable cardioverter defibrillators were common despite numerous device-related complications. Treatment failure was rare in the quarter of patients on flecainide. Left cardiac sympathetic denervation was not uncommon although the indication was variable.
Circulation | 2013
Jan Janousek; Irene E. van Geldorp; Sylvia Krupičková; Eric Rosenthal; Kelly Nugent; Maren Tomaske; Andreas Früh; Jan Elders; Anita Hiippala; Gunter Kerst; Roman Gebauer; Peter Kubuš; Patrick Frias; Fulvio Gabbarini; S. A. Clur; Bert Nagel; Javier Ganame; John Papagiannis; Jan Marek; Svjetlana Tisma-Dupanovic; Sabrina Tsao; Jan Hendrik Nürnberg; Christopher Wren; Mark K. Friedberg; Maxime De Guillebon; Julia Volaufova; Frits W. Prinzen; Tammo Delhaas
Background— We evaluated the effects of the site of ventricular pacing on left ventricular (LV) synchrony and function in children requiring permanent pacing. Methods and Results— One hundred seventy-eight children (aged <18 years) from 21 centers with atrioventricular block and a structurally normal heart undergoing permanent pacing were studied cross-sectionally. Median age at evaluation was 11.2 (interquartile range, 6.3–15.0) years. Median pacing duration was 5.4 (interquartile range, 3.1–8.8) years. Pacing sites were the free wall of the right ventricular (RV) outflow tract (n=8), lateral RV (n=44), RV apex (n=61), RV septum (n=29), LV apex (n=12), LV midlateral wall (n=17), and LV base (n=7). LV synchrony, pump function, and contraction efficiency were significantly affected by pacing site and were superior in children paced at the LV apex/LV midlateral wall. LV dyssynchrony correlated inversely with LV ejection fraction (R=0.80, P=0.031). Pacing from the RV outflow tract/lateral RV predicted significantly decreased LV function (LV ejection fraction <45%; odds ratio, 10.72; confidence interval, 2.07–55.60; P=0.005), whereas LV apex/LV midlateral wall pacing was associated with preserved LV function (LV ejection fraction ≥55%; odds ratio, 8.26; confidence interval, 1.46–47.62; P=0.018). Presence of maternal autoantibodies, gender, age at implantation, duration of pacing, DDD mode, and QRS duration had no significant impact on LV ejection fraction. Conclusions— The site of ventricular pacing has a major impact on LV mechanical synchrony, efficiency, and pump function in children who require lifelong pacing. Of the sites studied, LV apex/LV midlateral wall pacing has the greatest potential to prevent pacing-induced reduction of cardiac pump function.
Europace | 2014
Peter Kubuš; Pavel Vít; Roman Gebauer; Libor Zaoral; Petr Peichl; Martin Fiala; Jan Janousek
AIMS We aimed to evaluate long-term utilization and results of paediatric radiofrequency catheter ablation (RFCA) in a population-based study. METHODS AND RESULTS Data from all three centres performing paediatric RFCA for the whole population of the Czech Republic between 1993 and 2010 were retrospectively reviewed. A total of 708 ablation procedures in 633 consecutive patients <18 years for 716 different substrates were tracked, with accessory pathways = 439 (61.3%) and atrioventricular nodal reentry tachycardia (AVNRT) = 205 (28.6%) being most frequent. Incidence of RFCA reached 0.049 per 1000 children <18 years of age in the recent era (2006-10). Indications included patient preference (68.0%), drug refractoriness (15.5%), asymptomatic Wolff-Parkinson-White pre-excitation (8.4%), and malignant arrhythmia (6.1%). Median follow-up was 13.7 (interquartile range 5.7-21.5) months. Overall acute/long-term success of the primary procedure was 89.1/77.2% (accessory pathways 87.2/77.7%, AVNRT 98.5/84.4%). Re-ablation was performed in 73 of 163 substrates after a primary unsuccessful ablation resulting in a long-term cumulative efficacy of 96.3%. Between 1993-2005 and 2006-10, procedure/fluoroscopy time decreased from median 154/24 to 105/14 min. (P < 0.001 for both). Serious complications occurred in nine patients (1.4%). CONCLUSION This population-based study could replicate data from previous single- or multi-centre reports confirming RFCA as a safe method of arrhythmia treatment in children with long-term cumulative efficacy exceeding 90% and significant decrease in the procedure and fluoroscopy time during the study period. The need for RFCA can be estimated at ∼0.05/1000 children <18 years using current indication criteria.
Circulation | 2014
Peter Kubuš; Ondřej Materna; Petr Tax; Viktor Tomek; Jan Janousek
After repair of tetralogy of Fallot with significantly decreased exercise tolerance, a 17-year-old symptomatic boy underwent successful permanent resynchronization of a failing right ventricle (RV). The patient had surgical repair including pulmonary valvulotomy, infundibulectomy, and pericardial right ventricular outflow tract (RVOT) plasty at 1 year of age. At 3 years of age, he underwent resection of RVOT aneurysm, pulmonary valvuloplasty, and patch enlargement of the left pulmonary artery. Finally, a balloon pulmonary valvuloplasty of a mild residual pulmonary valve stenosis was performed at 17 years of age, resulting in a gradient reduction from 18 to 4 mm Hg and mild (grade I) pulmonary and tricuspid regurgitation. However, the patient continued to show significant RV dilation and systolic/diastolic dysfunction with signs of major RV dyssynchrony (right bundle-branch block; QRS duration of 200 ms and paradoxical interventricular septal …
Circulation-arrhythmia and Electrophysiology | 2014
Peter Kubuš; Pavel Vít; Roman Gebauer; Ondřej Materna; Jan Janousek
Background—Data on the results and clinical effect of an invasive risk stratification strategy in asymptomatic young patients with the Wolff–Parkinson–White electrocardiographic pattern are scarce. Methods and Results—Eighty-five consecutive patients aged <18 years with a Wolff–Parkinson–White pattern and persistent preexcitation at maximum exercise undergoing invasive risk stratification were retrospectively studied. Adverse accessory pathway (AP) properties were defined according to currently consented criteria as any of the following: shortest preexcited RR interval during atrial fibrillation/rapid atrial pacing ⩽250 ms (or antegrade effective refractory period ⩽250 ms if shortest preexcited RR interval was not available) or inducible atrioventricular re-entrant tachycardia. Age at evaluation was median 14.9 years. Eighty-two patients had a structurally normal heart and 3 had hypertrophic cardiomyopathy. A single manifest AP was present in 80, 1 manifest and 1 concealed AP in 4, and 2 manifest APs in 1 patient. Adverse AP properties were present in 32 of 85 patients (37.6%) at baseline and in additional 16 of 44 (36.4%) after isoproterenol. Ablation was performed in 41 of these 48 patients. Ablation was deferred in the remaining 7 for pathway proximity to the atrioventricular node. In addition, 18 of the low-risk patients were ablated based on patient/parental decision. Conclusions—Adverse AP properties at baseline were exhibited by 37.6% of the evaluated patients with an asymptomatic Wolff–Parkinson–White preexcitation persisting at peak exercise. Isoproterenol challenge yielded additional 36.4% of those tested at higher risk. Ablation was performed in a total of 69.4% of patients subjected to invasive risk stratification.
Heart Rhythm | 2014
Ondřej Materna; Peter Kubuš; Jan Janousek
1547-5271/
Current Opinion in Cardiology | 2014
Jan Janousek; Peter Kubuš
-see front matter B 2014 Heart Rhythm Society. All rights reserved. Introduction Although right ventricular (RV) dyssynchrony was previously identified as a possible cause of RV failure in patients with hypoplastic left heart syndrome (HLHS), cardiac resynchronization therapy (CRT) has rarely been reported as a treatment option. In this case, CRT by bifocal RV pacing induced sustained long-term improvement in RV function, enabling completion of Fontan palliation.
Europace | 2018
Pavel Vojtovič; Filip Kučera; Peter Kubuš; Roman Gebauer; Tomáš Matějka; Tomas Tlaskal; Miroslav Ložek; Jan Kovanda; Jan Janousek
Purpose of review To review and prioritize data on pediatric cardiac pacing published during the period of the last 18 months. Recent findings New approaches to preservation of ventricular function in pediatric pacing are based on recent publications confirming major influence of the ventricular pacing site on left ventricular (LV) function and synchrony. Current studies on epicardial vs. transvenous pacing continue to show survival superiority of endocardial leads. Long-term outcome of epicardial pacing may, however, be positively influenced by technical refinements. Recent amendments of the guidelines for cardiac resynchronization therapy (CRT) in adult idiopathic and ischemic cardiomyopathy are likely to influence CRT indications in children. Novel data give interesting insights into implantable cardioverter-defibrillator (ICD) lead survival as well as the use of ICDs in young patients with hypertrophic cardiomyopathy. Summary Pediatric cardiac pacing and ICD therapy is still a developing field likely to improve with technical refinements, proper lead placement and more specific therapy indications. The current review will give the reader information about recent developments and directions for the future.
Europace | 2018
Thomas M. Roston; Zhiguang Yuchi; Prince J. Kannankeril; Julie Hathaway; Jeffrey M. Vinocur; Susan P. Etheridge; James E. Potts; Kathleen R. Maginot; Jack C. Salerno; Mitchell I. Cohen; Robert M. Hamilton; Andreas Pflaumer; Saira Mohammed; Lynn Kimlicka; Ronald J. Kanter; Martin J. LaPage; Kathryn K. Collins; Roman Gebauer; Joel Temple; Anjan S. Batra; Christopher C. Erickson; Maria Miszczak-Knecht; Peter Kubuš; Yaniv Bar-Cohen; Michal J. Kantoch; Vincent C. Thomas; Gabriele Hessling; Chris Anderson; Ming Lon Young; Sally H.J. Choi
Aims Right bundle branch block is associated with right ventricular (RV) electromechanical dyssynchrony, which may contribute to acute haemodynamic impairment after repair of tetralogy of Fallot (ToF). We sought to evaluate the effects of RV resynchronization on haemodynamics and tissue oxygenation during the first 24 h after surgery. Methods and results Arterial pressures, cardiac output, and tissue oxygenation were measured in 28 consecutive patients (median age 10.1 months) during baseline sinus rhythm with right bundle branch block and after RV resynchronization by atrial-triggered RV free wall pacing in complete fusion with spontaneous activation. Studied variables were compared in a crossover design in four 5-min intervals (baseline rhythm and stimulation, 2x each). Resynchronization reduced the QRS complex duration from median 110 to 70 ms (P < 0.001), increased significantly median arterial systolic, mean and pulse pressure, cardiac index, left ventricular maximum +dP/dT and decreased central venous pressure (P < 0.001 for all). Both cerebral and renal oxygenation improved (P < 0.001). Eleven of the 28 patients showed a clinically highly significant resynchronization effect defined as an increase in arterial pulse pressure of ≥ 10%. The q-RV interval (expressed as % of QRS duration) at the RV pacing site during baseline rhythm was the only predictor of resynchronization effect. Conclusions RV resynchronization carried short-term improvement of haemodynamics in children early after surgery for ToF and might be a useful non-pharmacologic adjunct to the management of haemodynamically compromised patients. Resynchronization effect was maximized when pacing from area of the latest RV activation.
Circulation-cardiovascular Imaging | 2017
Jan Janousek; Jan Kovanda; Miroslav Ložek; Viktor Tomek; Pavel Vojtovič; Roman Gebauer; Peter Kubuš; Miroslav Krejčíř; Joost Lumens; Tammo Delhaas; Frits W. Prinzen
Aims Catecholaminergic polymorphic ventricular tachycardia (CPVT) is an ion channelopathy characterized by ventricular arrhythmia during exertion or stress. Mutations in RYR2-coded Ryanodine Receptor-2 (RyR2) and CASQ2-coded Calsequestrin-2 (CASQ2) genes underlie CPVT1 and CPVT2, respectively. However, prognostic markers are scarce. We sought to better characterize the phenotypic and genotypic spectrum of CPVT, and utilize molecular modelling to help account for clinical phenotypes. Methods and results This is a Pediatric and Congenital Electrophysiology Society multicentre, retrospective cohort study of CPVT patients diagnosed at <19 years of age and their first-degree relatives. Genetic testing was undertaken in 194 of 236 subjects (82%) during 3.5 (1.4-5.3) years of follow-up. The majority (60%) had RyR2-associated CPVT1. Variant locations were predicted based on a 3D structural model of RyR2. Specific residues appear to have key structural importance, supported by an association between cardiac arrest and mutations in the intersubunit interface of the N-terminus, and the S4-S5 linker and helices S5 and S6 of the RyR2 C-terminus. In approximately one quarter of symptomatic patients, cardiac events were precipitated by only normal wakeful activities. Conclusion This large, multicentre study identifies contemporary challenges related to the diagnosis and prognostication of CPVT patients. Structural modelling of RyR2 can improve our understanding severe CPVT phenotypes. Wakeful rest, rather than exertion, often precipitated life-threatening cardiac events.